Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 245

Sort by

Sort Order Select

Journal Articles

HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern

Blood (2020) 136 (11): 1351–1358.

https://doi.org/10.1182/blood.2020006890

Published: 2020

Includes: Supplemental data

Journal Articles

HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

Eduard Grebe, Michael P. Busch, Edward P. Notari, Roberta Bruhn, Claire Quiner, Daniel Hindes, Mars Stone, Sonia Bakkour, Hong Yang, Phillip Williamson, Debra Kessler, Rita Reik, Susan L. Stramer, Simone A. Glynn, Steven A. Anderson, Alan E. Williams, Brian Custer

Blood (2020) 136 (11): 1359–1367.

https://doi.org/10.1182/blood.2020007003

Published: 2020

Includes: Supplemental data

Journal Articles

Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials

Blood (2019) 134 (Supplement_1): 4525.

https://doi.org/10.1182/blood-2019-129488

Published: 2019

Journal Articles

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

Ali Unal, MD, Serhat Çelik, Zeynep Güven, MD, Leylagul Kaynar, MD, Bulent Eser, MD, Mustafa Çetin

Blood (2019) 134 (Supplement_1): 5359.

https://doi.org/10.1182/blood-2019-123387

Published: 2019

Journal Articles

Plasmablastic Lymphoma in a Community-Based Cancer Center: A 10-Year Analysis of This Rare Disease in a Underserved Urban Area

Vinicius Machado Jorge, MD, Andrew Tiu, MD, Sorab Gupta, MD, Claudia Dourado, MD, Gabor Varadi, MD

Blood (2019) 134 (Supplement_1): 5361.

https://doi.org/10.1182/blood-2019-131905

Published: 2019

Journal Articles

Prognosis in Patients with Human Immunodeficiency Virus Infection and Advanced Clinical Stage Classic Hodgkin's Lymphoma

Juan J delMoral-Diez, MD, Elena Juventina Tuna-Aguilar, MD, Alvaro Aguayo, MD, Antonio Olivas-Martinez, MD, Gladys P Agreda-Vasquez, MD

Blood (2019) 134 (Supplement_1): 5281.

https://doi.org/10.1182/blood-2019-123792

Published: 2019

Journal Articles

Plasmablastic Lymphoma - Experience with Infusional EPOCH Chemotherapy from India

Jayachandran PK, MD MRCP, DM, Arun Kumar Rajan, MD DM, Nikita Mehra, MD DM, Gangothri Selvarajan, MD DM, Joshi Archit Girishchandra, MD DM, Parathan Karunakaran, MD DM, Manikandan Dhanushkodi, MD DM, Venkatraman Radhakrishnan, MD DM, Krishnarathinam Kannan, MD DM, Trivadi S Ganesan, MD FRCP, PhD, Tenali Gnana Sagar, MD DM

Blood (2019) 134 (Supplement_1): 5351.

https://doi.org/10.1182/blood-2019-127158

Published: 2019

Journal Articles

Short-Course Therapy in Newly Diagnosed Immunodeficiency-Associated Aggressive B-Cell Lymphoma

Rami Alsharif, MD, Samah Nassereddine, MD, Esma Akin, MD, Donald Karcher, MD, Mitchell Smith, MD PhD, Eduardo Sotomayor, MD, Kieron Dunleavy, MD

Blood (2019) 134 (Supplement_1): 5355.

https://doi.org/10.1182/blood-2019-124081

Published: 2019

Journal Articles

Hodgkin Lymphoma Outcomes: Can We Expect Ethnic Parity in a Hispanic Prevalent Population?

Michelle Janania Martinez, MD, Prathibha Surapaneni, MD, Juan F Garza, MD, Tyler W Snedden, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD

Blood (2019) 134 (Supplement_1): 4056.

https://doi.org/10.1182/blood-2019-129058

Published: 2019

Journal Articles

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 4016.

https://doi.org/10.1182/blood-2019-129212

Published: 2019

Journal Articles

Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda

Cyprien Shyirambere, MD, Rebecca Deboer, MD, Yvan Butera, MD, Caitlin Driscoll, resident, Jean Bosco Bigirimana, Francois Regis Uwizeye, Temidayo Fadelu, MD, Paul H Park, MD, Alan Paciorek, Leslie E. Lehmann, MD, Lawrence N. Shulman, MD

Blood (2019) 134 (Supplement_1): 4053.

https://doi.org/10.1182/blood-2019-130780

Published: 2019

Journal Articles

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Blood (2019) 134 (Supplement_1): 2584.

https://doi.org/10.1182/blood-2019-125683

Published: 2019

Journal Articles

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

Blood (2019) 134 (Supplement_1): 1619.

https://doi.org/10.1182/blood-2019-131435

Published: 2019

Journal Articles

Acute Leukemia and High-Risk Myelodysplastic Syndromes in HIV-Positive Patients: 25-Years' Experience of the Rete Ematologica Lombarda (REL)

Chiara Cattaneo, MD, Massimo Bernardi, MD, Valentina Mancini, MD, Chiara Pagani, MD, Monica Fumagalli, MD, Patrizia Zappasodi, MD, Erika Borlenghi, MD, Alessandro Re, MD, Fabio Ciceri, MD, Margherita Sciumé, Roberto Cairoli, MD, Giuseppe Rossi

Blood (2019) 134 (Supplement_1): 3603.

https://doi.org/10.1182/blood-2019-125288

Published: 2019

Journal Articles

A Multicenter, Open-Label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Carlyn Rose Tan, MD, Stefan K. Barta, MD MRCP, MS, Shelly Y. Lensing, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1595.

https://doi.org/10.1182/blood-2019-129702

Published: 2019

Journal Articles

Exploring the Safety and Efficacy of Upfront Autologous Stem Cell Transplantation with LEED Preconditioning for Primary Central Nervous System Lymphoma

Hirofumi Yokota, MD, Kotaro Miyao, MD PhD, Fumiya Ohara, MD, Kenta Motegi, MD, Hiroya Wakabayashi, MD, Yuki Takeuchi, MD, Shihomi Kuwano, MD, Hitomi Sawa, MD, Yuichiro Inagaki, MD PhD, Masashi Sawa, MD PhD

Blood (2019) 134 (Supplement_1): 1611.

https://doi.org/10.1182/blood-2019-123703

Published: 2019

Journal Articles

Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - a Multicenter Cohort Study

Wellington F Silva, MD, Pedro Marques Garibaldi, MD, Lidiane Inês Da Rosa, MD, Marcelo Bellesso, MD, Diego V Clé, MD PhD, Marcia Torresan Delamain, MD, Eduardo M Rego, MD PhD, Juliana Pereira, MD PhD, Vanderson Rocha, MD PhD

Blood (2019) 134 (Supplement_1): 1616.

https://doi.org/10.1182/blood-2019-129627

Published: 2019

Journal Articles

Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy

Daniel J. Landsburg, MD, Mitchell E. Hughes, PharmD, Alexa Koike, David A. Bond, MD, Kami J. Maddocks, MD, Ling Guo, MD, Allison M. Winter, MD, Brian T. Hill, MD PhD, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Agata M. Bogusz, MDPhD

Blood (2018) 132 (Supplement 1): 455.

https://doi.org/10.1182/blood-2018-99-117514

Published: 2018

Journal Articles

Addition of Rituximab to High-Dose Methotrexate Regimens Improves Complete Response Rates and Median Overall Survival in Non-Germinal Center Primary CNS Lymphoma

Neelam Mistry, MD, Derek E Smith, MS, Manali Kamdar, MD, Bradley M. Haverkos, MD MPH, MS, Douglas Ney, MD

Blood (2018) 132 (Supplement 1): 4217.

https://doi.org/10.1182/blood-2018-99-112686

Published: 2018

Journal Articles

Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy

Emily C. Ayers, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, David A. Bond, MD, Kami J. Maddocks, MD, Pallawi Torka, MD, Angel Mier Hicks, MD, Madeira Curry, Nina D. Wagner-Johnston, MD, Reem Karmali, MD, Amir Behdad, MD, Bita Fakhri, MDMPH, Brad S Kahl, MD, Michael C Churnetski, BS, Jonathon B. Cohen, MDMS, Nishitha Reddy, MD, Dipenkumar Modi, MD, Radhakrishnan Ramchandren, MD, Christina Howlett, PharmD, BCOP, Lori A. Leslie, MD, Samuel Cytryn, Catherine Diefenbach, MD, Rawan Faramand, MD, Julio C. Chavez, MD, Adam J Olszewski, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Dhruvika Mukhija, MD, Brian T. Hill, MD PhD, Helen Ma, MD, Jennifer E Amengual, MD, Sunita Nathan, MD, Sarit Assouline, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Ashwin Chandar, MD, Kevin A. David, MD, Anshu Giri, MD, Brian T. Hess, MD, Daniel J. Landsburg, MD

Blood (2018) 132 (Supplement 1): 453.

https://doi.org/10.1182/blood-2018-99-115527

Published: 2018

NARROW

HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern

HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

Plasmablastic Lymphoma in a Community-Based Cancer Center: A 10-Year Analysis of This Rare Disease in a Underserved Urban Area

Prognosis in Patients with Human Immunodeficiency Virus Infection and Advanced Clinical Stage Classic Hodgkin's Lymphoma

Plasmablastic Lymphoma - Experience with Infusional EPOCH Chemotherapy from India

Short-Course Therapy in Newly Diagnosed Immunodeficiency-Associated Aggressive B-Cell Lymphoma

Hodgkin Lymphoma Outcomes: Can We Expect Ethnic Parity in a Hispanic Prevalent Population?

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

Acute Leukemia and High-Risk Myelodysplastic Syndromes in HIV-Positive Patients: 25-Years' Experience of the Rete Ematologica Lombarda (REL)

A Multicenter, Open-Label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Exploring the Safety and Efficacy of Upfront Autologous Stem Cell Transplantation with LEED Preconditioning for Primary Central Nervous System Lymphoma

Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - a Multicenter Cohort Study

Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy

Addition of Rituximab to High-Dose Methotrexate Regimens Improves Complete Response Rates and Median Overall Survival in Non-Germinal Center Primary CNS Lymphoma

Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only